John DeFlice, M.D. is a ten-year multiple myeloma survivor. He had a stem cell transplant at Cedars-Sinai Samuel Oschin Cancer Center in Los Angeles in 2011and is currently on maintenance therapy. John is a co-lead of the International Myeloma Foundation support group in Santa Fe, New Mexico, and has attended ASH at the invitation of the IMF for four years. He will again be participating in the virtual ASH 2021. 

Follow John on Twitter: @JohnDe1MYELOMA
Support Group Website: The Land of Enchantment Myeloma Support Group

 

 

Post-ASH: Seeing in the Sand

Post-ASH: Seeing in the Sand

Dec 16, 2021 |

“Any fool can turn a blind eye but who knows what the ostrich sees in the sand.” - Samuel Barclay Beckett Colon cancer screening has been shown to reduce the incidence of colon cancer in the general population by identifying premalignant lesions in the colon and treating them. Can screening for elevated blood proteins impact a specific blood cancer? Multiple myeloma (MM) evolves from monoclonal gammopathy of undetermined significance (MGUS) which is completely asymptomatic. In an attempt to...

read more
Connecting with Others

Connecting with Others

Dec 12, 2021 |

“The most important things in life are the connections you make with others.”—Tom Ford While I am grateful to be attending ASH 2021 virtually this year, I do miss the experience of interacting with my fellow International Myeloma Foundation (IMF) Support Group Leaders (SGLs). I have fond memories of sharing meals with other SGLs and learning so much about their families, their professions, and the impact that myeloma has on their lives. I still remember my first ASH experience where I learned...

read more
With a goal of CURE

With a goal of CURE

Dec 12, 2021 |

“The difference between the impossible and the possible lies in a man’s determination.”-Tommy Lasorda The International Myeloma Foundation's International Myeloma Working Group (IMWG) Symposium included case discussions that highlighted emerging topics in multiple myeloma. Dr. Jesus San Miguel (Clinica Universidad de Navarra - Navarra, Spain) presented the first case. His presentation involved The treatment of high-risk smoldering multiple myeloma (HRSMM). During his presentation, he convinced...

read more
Pre-ASH Blog: To Think What Nobody Else Has

Pre-ASH Blog: To Think What Nobody Else Has

Dec 6, 2021 |

“Research is to see what everybody has seen, and to think what nobody else has.” Albert Szent-Gyorgyi I tweeted the above quote after Dr. Ola Landgren (Sylvester Comprehensive Cancer Center at the University of Miami — Florida) had spoken to our International Myeloma Foundation (IMF) virtual support group in New Mexico.   Dr. Landgren, a myeloma expert, discussed new myeloma treatments and shared his new lines of research at the Sylvester Comprehensive Cancer Center in Miami—South...

read more